Euclidean Technologies commentary for the second quarter ended June 2020, titled, "Quantifying Margin of Safety."
Q2 2020 hedge fund letters, conferences and more
Although having recovered a good deal since the March lows, value strategies like Euclidean’s continue to suffer disproportionately during the pandemic. I am reluctant to assign a cause to why one part of the market is performing better than another, but the pain experienced by small-cap value funds during COVID-19 is likely due to the fact that investors see large companies as more impervious to the economic fallout of the pandemic (warranted or not). With that said, history clearly reveals that our style of investing would have outperformed over long periods of time. And nonetheless,...
Login required to continue reading.
Setup a free account to get access to this article (no credit card required).
View Full Article
